Winton Matthew 4
4 · Inozyme Pharma, Inc. · Filed Jun 27, 2025
Insider Transaction Report
Form 4
Transactions
- Award
Common Stock
2025-06-25$0.74/sh+14,355$10,623→ 21,743 total
Footnotes (1)
- [F1]Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 1, 2025 through June 25, 2025. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on April 1, 2025, the first trading day of the purchase period.